✦ LIBER ✦

General Framework for the Prediction of Oral Drug Interactions Caused by CYP3A4 Induction fromIn VivoInformation

✍ Scribed by Yoshiyuki Ohno, Dr Akihiro Hisaka, Masaki Ueno, Hiroshi Suzuki

Book ID: 119926886
Publisher: Springer International Publishing AG
Year: 2008
Tongue: English
Weight: 200 KB
Volume: 47
Category: Article
ISSN: 0312-5963
DOI: 10.2165/00003088-200847100-00004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

General Framework for the Quantitative P

General Framework for the Quantitative Prediction of CYP3A4-Mediated Oral Drug Interactions Based on the AUC Increase by Coadministration of Standard Drugs

✍ Yoshiyuki Ohno, Dr Akihiro Hisaka, Hiroshi Suzuki 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 276 KB

Drug interactions with mitotane by induc

Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma

✍ Matthias Kroiss; Marcus Quinkler; Werner K. Lutz; Bruno Allolio; Martin Fassnach 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Effects of myricetin on the bioavailabil

Effects of myricetin on the bioavailability of doxorubicin for oral drug delivery in Rats: Possible role of CYP3A4 and P-glycoprotein inhibition by myricetin

✍ Sang-Joon Choi; Sang-Chul Shin; Jun-Shik Choi 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 405 KB

Studies on the Interactions between Drug

Studies on the Interactions between Drugs and Estrogen: Analytical Method for Prediction System of Gynecomastia Induced by Drugs on the Inhibitory Metabolism of Estradiol Using Escherichia coli Coexpressing Human CYP3A4 with Human NADPH-Cytochrome P450 Reductase

✍ Takashi Satoh; Ken-ichi Fujita; Haruka Munakata; Shinji Itoh; Katsunori Nakamura 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 94 KB

To establish a prediction system for drug-induced gynecomastia in clinical fields, a model reaction system was developed to explain numerically this side effect. The principle is based on the assumption that 50% inhibition concentration (IC 50 ) of drugs on the in vitro metabolism of estradiol (E2)